CCM
TYRA icon

Cinctive Capital Management’s Tyra Biosciences TYRA Stock Holding History

Cinctive Capital Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$325K Sell
10,184
-67,834
-87% -$2.24M 0.01% 382
2026
Q1 		$2.99M Buy
+78,018
New +$2.53M 0.19% 168
2024
Q4 		– Sell
-22,900
Closed -$538K – 487
2024
Q3 		$538K Buy
+22,900
New +$481K 0.03% 338

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Cinctive Capital Management's TYRA Position: Q2 2026 in Review

Cinctive Capital Management reduced its Tyra Biosciences (TYRA) stake by 87% in Q2 2026, selling an estimated $2.24M and leaving 10,184 shares worth $325K. The position accounts for 0.01% of the portfolio, ranked #382.

Cinctive Capital Management first reported a position in TYRA in Q3 2024 and has held it in 3 quarters since. The position peaked at $2.99M in Q1 2026. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Cinctive Capital Management held 10,184 shares of Tyra Biosciences worth $325K as of Q2 2026.
  • Cinctive Capital Management sold 67,834 Tyra Biosciences shares in Q2 2026, an estimated $2.24M.
  • Tyra Biosciences made up 0.01% of Cinctive Capital Management's portfolio in Q2 2026, its #382 holding.
  • Cinctive Capital Management first reported a position in Tyra Biosciences in Q3 2024 and has held it in 3 quarters since.
  • Cinctive Capital Management's Tyra Biosciences position peaked at $2.99M in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.